|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | HER-2 amplification and topoisomerase 11 alpha gene aberration as predictive markers in node - positive breast cancer patients randomly treated either withan anthracycline - based therapy or with eyclophosphamide, methotrexate, and 5 - fluorouracil显示文摘 | Di Leo A Gabcberg D Larsimont D | 2002 | Clinical Cancer Res2002，8，： | 1 |
| 2 | Cancer cells in epithelial-to-mesenchymal transition and tumor- propagating-cancer stem cells : distinct, overlapping or same populations 显示文摘 | Floor S van Staveren WC Larsimont D | 2011 | Oncogene2011，30，： | 1 |
| 3 | HER-2 and topoi- somerase llalpha as predictive cancer patients randomly treated with adjuvant CMF or epirubicin plus cyelophosphamide显示文摘 | Di Leo A Larsimont D Gabcberg D | 2001 | Ann Oncol2001，12，： | 1 |
| 4 | HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide显示文摘 | Leo AD Larsimont D Gancberg D | 2001 | Ann Oncol2001，12，： | 1 |
| 5 | HER-2amplification and topoisomerase Ⅱalpha gene aberrationsas predictive markers in node-positive breast cancerpatients randomly treated either with an anthracycline-based therapy or with cyclophosphamide,methotrexate,and 5-fluorouracil显示文摘 | Di LA Gancberg D Larsimont D | 2002 | Clin Cancer Res2002，8，5： | 1 |
| 6 | Decrease of estrogen receptor expression and associated ERE-dependent transcription in MCF-7 breast cancer cells after oligomycin treatment 显示文摘 | Seo H S Joume F Larsimont D | 2003 | Steroids2003，68，3： | 1 |
| 7 | Predictingthe efficacy of anthracyclines in breast cancer(BC)patients:Results of the neoadjuvant TOP trial显示文摘 | Desmedt C Azambuja E Larsimont D | 2009 | J ClinOncol2009，27，15： | 1 |
| 8 | HER2 ampli- fication and topoisomerase Ⅱ alpha gene aberrations as predictive markers in nodepositive breast cancer patients randomly treated ei- ther with an anthracycline - based therapy or with cyclophospha- mide, methotrexate, and 5 - fluorouracil 显示文摘 | DI LEO A GANCBERG D LARSIMONT D | 2002 | Clin Cancer Res2002，8，5： | 1 |
| 9 | Correlationbetween complete response to anthracycline-basedchemotherapy and topoisomerase II-alpha geneamplification and protein overexpression in locallyadvanced/metastatic breast cancer显示文摘 | Cardoso F Durbecq V Larsimont D | 2004 | Int J Oncol2004，24，1： | 1 |
| 10 | HER-2 amplification and Topoisomerase Ⅱαgene aberrations as predictive marker in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil显示文摘 | Di Leo A Gancberg D Larsimont D | 2002 | Clin Cancer Res2002，8，5： | 1 |
| 11 | Evaluation of HER2,p53,bcl-2,topoisome rase Ⅱ-alpha,heat shock proteins 27 and 70 in primary breast cancer and metastatic ipslateral axillary lymph nodes显示文摘 | Cardoso F Di Leo A Larsimont D | 2001 | Ann Oncol2001，12，： | 1 |
| 12 | HER-2andtopo-isomerase Ⅱalpha as predictive markers in apopulation of node-positive breast cancer patientsrandomly treated with adjuvant CMF or epirubicin pluscyclophosphamide显示文摘 | Di Leo A Larsimont D Gancberg D | 2001 | Ann Oncol2001，12，8： | 1 |
| 13 | HER2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracyclinebased therapy or with cyclophosphamide, methotrexatc, and 5-fluorouracil 显示文摘 | Di Leo A Gancberg D Larsimont D | 2002 | Clin Cancer Res2002，8，5： | 1 |
| 14 | Decrease of estrogen receptor expression and associated ERE-dependent transcription in MCF-7 breast cancer cells after oligomycin treatment 显示文摘 | Seo HS Journe F Larsimont D | 2003 | Steroids2003，68，3： | 1 |
| 15 | Wide localized excision and reconstruction for minor salivary gland tumours 显示文摘 | Dequanter D Andry G Larsimont D | 2005 | BENT2005，1，4： | 1 |
| 16 | Wide localized excision and reconstruction for minor salivary gland tumours显示文摘 | Dequanter D Andry G Larsimont D | 2005 | B-ENT2005，1，4： | 1 |
| 17 | HER-2 and topo-isomerase IIct as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide 显示文摘 | Di Leo A Larsimont D Gabcberg D | 2001 | Ann Oncol2001，，8： | 1 |
| 18 | Evaluation of HER2,P53,bcl-2,topoisomerase Ⅱ-alpha,heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes显示文摘 | Cardoso F Di Leo A Larsimont D | 2001 | Ann Oncol2001，12，5： | 1 |
| 19 | Cancer cellsin epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells:distinct,overlapping orsame populations显示文摘 | Floor S van Staveren WC Larsimont D | 2011 | Oncogene2011，30，46： | 1 |
| 20 | Change in the microenvironment of breast cancer studied by FTIR imaging显示文摘 | KUMAR S DESMEDT C LARSIMONT D | 2013 | Analyst2013，138，14： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员